fbpx

Year

2017
Most ESRD patients, in the last stage of chronic kidney disease, suffer from accelerated cardiovascular calcification, which correlates with higher cardiovascular risk. Cardiovascular disease is the most common cause of death in patients with ESRD and there are currently no approved therapies for the treatment of CVC. SNF472 is being developed to address this significant...
Ny rapport fra Aarhus Universitet viser, at dansk hjerneforskning sammenlignet med andre lande er i en rivende udvikling, men at der er fortsat er meget at stræbe efter for at blive blandt verdens førende Dansk hjerneforskere er dygtigere end nogensinde til at skabe videnskabelige resultater. Målt på antallet af offentliggjorte videnskabelige publikationer er Danmark i...
Neuropsychiatrist Mark Walterfang, MBBS Hons, PhD, FRANZCP, Associate Professor at The Royal Melbourne Hospital, and clinical investigator in the VTS-270 trial, said: “We are honored to lead the way in bringing to Australia this important clinical study, through which we are evaluating the intrathecal use of VTS-270 in children with NPC. There is an urgent unmet global need for...
Hvad afgør om vi er tykke eller tynde? Hvorfor er det så svært at opretholde et ønsket vægttab? Har vi selv kontrollen, eller er det styret af hjernekemi og evolution? Og kan man tale om rigtigt og forkert kropsfedt i det moderne samfund? Kropsfedt har i mange år været tabu i den vestlige verden, men...
“We are very pleased with the strong interest in this financing round from leading life science and strategic corporate investors,” said Pieter Muntendam, MD, founder, president and CEO of scPharmaceuticals. “The additional funds will support our preparation for the commercial introduction of Furoscix and the sc2Wear Infusor, as well as further development of our antibiotic pipeline...
“As we near completion of enrollment in our pivotal Phase 2b/3 clinical trial of our lead drug candidate, VTS-270, our primary goal is to advance regulatory submissions. Assuming we receive favorable responses from U.S. and European regulatory agencies, our next goal will be to rapidly provide access to VTS-270 for the children suffering from NPC...
1 12 13 14

Nyheder

Lundbeckfonden
Hjernesygdomme koster samfundet mindst 39 mia. kroner
18. november 2020
Danske forskere leverer beviset: Kejsersnit kan lede til astma og allergi
12. november 2020
En helt ny slags ’antabus’ – men mod kokainmisbrug
10. november 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge